Zoetis Inc. (ZTS) Social Stream



Zoetis Inc. (ZTS): $163.05

0.05 (+0.03%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Zoetis Inc (ZTS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Zoetis Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 12 $258 $184 $234.625 $191.32 22.63%
2021-11-18 13 $264 $184 $239 $191.32 24.92%
2021-12-10 13 $264 $184 $242.555 $191.32 26.78%
2022-01-03 13 $264 $232 $247.888 $191.32 29.57%
2022-02-16 13 $275 $232 $250.666 $191.32 31.02%
2022-03-16 13 $275 $230 $249.666 $191.32 30.5%

The Trend in the Analyst Price Target


Over the past 22 months, ZTS's average price target has gone up $109.24.

Over the past 131 days, ZTS's average upside potential has been 18.39%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-18 13 264 184 239.000 225.54 5.97%
2022-01-03 13 264 232 247.888 234.03 5.92%
2022-01-31 13 275 232 250.666 199.79 25.46%
2022-02-14 13 275 232 250.666 196.43 27.61%
2022-02-16 13 275 232 250.666 195.09 28.49%

ZTS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.35 10 1 2 0 0 13

The Trend in the Broker Recommendations


Over the past 19 months, ZTS's average broker recommendation rating improved by 0.46.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ZTS as an investment opportunity.

  • Zoetis Inc's average analyst price target is higher than 640.17% of all US stocks.
  • In the context of Pharmaceutical Products stocks, Zoetis Inc's number of analysts covering the stock is higher than 613.67% of them.
  • In terms of how Zoetis Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 86.91% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Zoetis Inc's variance in analysts' estimates is lower than -39.58% of them.

In the Pharmaceutical Products industry, ZLAB, VTRS, and VRTX are the three stocks most similar to Zoetis Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ZTS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6973 seconds.